HHS releases new buprenorphine practice guidelines, relaxing waiver requirements

Bricker & Eckler LLP
Contact

Bricker & Eckler LLP

The Department of Health and Human Services (HHS) recently released new practice guidance on buprenorphine administration in an effort to make evidence-based treatment for opioid use disorder more accessible to persons suffering with opioid addiction. According to a related press release issued by HHS, overdose deaths have increased during COVID-19 and are at an all-time high, making treatment accessibility imperative.

Generally, in order to prescribe buprenorphine, a medication used for the treatment of opioid use disorder, a practitioner must be separately registered or obtain a waiver from the separate registration requirement. Among other things, the new guidelines remove a long-standing training requirement for obtaining a waiver. Practitioners frequently cite this training requirement as an obstacle to treating patients with opioid use disorder.

Under the new guidelines, eligible physicians, physicians assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and certified nurse midwives are exempt from federal certification requirements related to training, counseling and other ancillary services (i.e., psychosocial services), that are generally required to obtain a waiver, and practitioners can treat up to 30 patients without meeting those requirements.

Notably, eligible practitioners must still apply for and obtain the waiver to treat up to 30 patients and the cited certification requirements continue to apply to providers wishing to treat more than 30 patients.

The Ohio Board of Pharmacy has issued a guidance document summarizing some of the HHS guidance, including the rules for waivers under the new HHS buprenorphine practice guidelines.

[View source.]

Written by:

Bricker & Eckler LLP
Contact
more
less

Bricker & Eckler LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.